Efficacy and safety of bromelain: A systematic review and meta-analysis
Nutrition and Health · 2023-09 · 29 (3) · 479-503
DOI: 10.1177/02601060231173732 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Nutrition and Health, online erschienen am 08.05.2023. Verfasst von Nattawut Leelakanok und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Burapha University, Chonburi, Thailand. Hauptthemen laut MEDLINE: Bromelains, Ananas. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: Nova Organic.
Abstract (Originalsprache)
Background
Pineapple has an important role in ethnopharmacology and its enzyme, bromelain, has been extensively investigated for its medicinal properties.
Aim
This systematic review and meta-analysis aimed to assess clinical evidence concerning the efficacy and safety of bromelain.
Methods
A systematic search was conducted from conception to August 2022 using CINAHL Complete, MEDLINE, ScienceDirect, Scopus, and Thai Journal Online (TJO). The risk of bias was assessed using Risk of Bias 2 or ROBIN-I. A random-effect model with inverse variance weighting and DerSimonian and Laird method was used for meta-analysis. The heterogeneity was evaluated by I 2 statistics.
Results
We included 54 articles for qualitative summary and 39 articles for meta-analysis. The systematic review found that bromelain presented in serum with retained proteolytic activity after oral absorption. Bromelain may be effective against sinusitis but was not effective for cardiovascular diseases. Pain reduction from oral bromelain was slightly but significantly better than controls (mean difference in pain score = -0.27; 95% CI: −0.45, −0.08; n = 9; I 2 = 29%). Adverse events included flatulence, nausea, and headache. Topical bromelain significantly reduced the time to complete debridement (mean difference in time = -6.89 days; 95% CI: −7.94, −5.83; n = 4; I 2 = 2%). Adverse events may be irrelevant and include burning sensation, pain, fever, and sepsis.
Conclusions
Moderate-quality studies demonstrated the potential of oral bromelain in pain control and topical bromelain in wound care. Major health risks were not reported during the treatment with bromelain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmaceutical Sciences, Burapha University, Chonburi, Thailand.
- Research Unit of Pharmaceutical Innovations of Natural Products (PhInNat), Burapha University, Chonburi, Thailand.
- Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
- Faculty of Medical Technology, Prince of Songkla University, Songkhla, Thailand.
- The Government Pharmaceutical Organization, Bangkok, Thailand.
ORCID-Profile: Nattawut Leelakanok, Arpa Petchsomrit
Förderung
- Nova Organic
Zitieren
APA
Leelakanok, N., Petchsomrit, A., Janurai, T., Saechan, C., & Sunsandee, N. (2023). Efficacy and safety of bromelain: A systematic review and meta-analysis. Nutrition and Health, 29(3), 479-503. https://doi.org/10.1177/02601060231173732
Vancouver
Leelakanok N, Petchsomrit A, Janurai T, Saechan C, Sunsandee N. Efficacy and safety of bromelain: A systematic review and meta-analysis. Nutrition and Health. 2023;29(3):479-503. doi:10.1177/02601060231173732
BibTeX
@article{Leelakanok2023,
author = {Leelakanok, Nattawut and Petchsomrit, Arpa and Janurai, Thitapa and Saechan, Charinrat and Sunsandee, Niti},
title = {Efficacy and safety of bromelain: A systematic review and meta-analysis},
journal = {Nutrition and Health},
year = {2023},
volume = {29},
number = {3},
pages = {479--503},
doi = {10.1177/02601060231173732}
}
EUVIMED